Hyderabad: Dr Reddy’s Laboratories received final approval of its Abbreviated New Drug Application (ANDA) from US Food and Drug Administration (USFDA) for Lenalidomide capsules, in 2.5 mg and 20 mg strengths, and tentative approval for 5 mg, 10 mg, 15 mg, and 25 mg strengths, a therapeutic equivalent generic version of Revlimid (lenalidomide). With this […]
With herd immunity and a significant percentage of the US population vaccinated, the pandemic is reducing, and keeping this in view, the USFDA communicated that no new emergency use authorization would be approved for new Covid-19 vaccines
The company said the tablet is the bioequivalent and therapeutically equivalent to the Theophylline extended-release tablets, 300 mg and 450 mg, of Alembic Pharmaceuticals Limited.
Quoting IQVIA sales data for the 12 month period ending April 2021, Glenmark Pharma said the Banzel tablets, 200 mg and 400 mg market achieved annual sales of approximately USD 285.3 million.
He also said that this is the time to invoke the compulsory licensing provisions in the law, so that a number of companies are able to produce the vaccines under a licence
As per the latest Enforcement Report issued by USFDA, the Salisbury-based Jubilant Cadista is recalling the drug for "failed tablet/capsule specification"
As per the USFDA, Marksans Pharma is recalling close to six lakh bottles of diabetes drug Metformin Hydrochloride extended-release tablets in strengths of 500 mg and 750 mg in the US market
Lupin said it does not believe that the observations will have an impact on disruption of supplies or the existing revenues from operations of this facility
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad, it added. Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control